Partner Kristine Kraft Appointed to the Plaintiffs’ Steering Committee (PSC) in Federal Testosterone Replacement Therapy MDL, Schlichter, Bogard & Denton, LLP Reports

Kristine Kraft, a partner at Schlichter, Bogard & Denton, LLP, has been appointed to the Plaintiffs’ Steering Committee in the Low-T Multidistrict Litigation (MDL 2545) pending in the United States District Court for the Northern District of Illinois. The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have been injured after using testosterone products.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Kristine Kraft of Schlichter, Bogard & Denton, LLP

I am honored to have been appointed as a leader in this litigation and eager to fight for the rights of victims who allege suffering injuries after using these drugs.

St. Louis, MO (PRWEB) August 13, 2014

A federal judge recently appointed Kristine Kraft, a partner at Schlichter, Bogard & Denton, LLP, to the Plaintiffs’ Steering Committee (PSC) in the Multidistrict Litigation (MDL) involving the manufacturers of low testosterone replacement therapies (Case Management Order No. 4, In Re: Testosterone Therapy Products Liability Litigation, Case No. 1:14-cv-1748, MDL No. 2545, N.D. Ill.). The Honorable Matthew F. Kennelly of the U.S. District Court for the Northern District of Illinois appointed Kraft to the PSC in July 2014. Kraft and other appointed co-counsel will be leaders in the national litigation involving victims who allege to have been seriously injured while using testosterone replacement therapies.

“We continue to hear from individuals who allege to have experienced life-threatening and serious injuries after using testosterone products,” says Kraft. “I am honored to have been appointed as a leader in this litigation and eager to fight for the rights of victims who allege suffering injuries after using these drugs.” The attorneys at Schlichter, Bogard & Denton, LLP are offering free and confidential case reviews to those who allege to have been injured after using testosterone products.

On January 31, 2014, the United States Food and Drug Administration (FDA) issued a Safety Announcement that it is investigating a potential link between testosterone use and stroke, myocardial infarction (MI), and death, as demonstrated by published studies. The first study that prompted the FDA’s Safety Announcement was published in the Journal of the American Medical Association (JAMA) in November 2013 and suggested that testosterone replacement drugs may increase the risk of heart attack, stroke and death. The second study, published in the online journal PLos ONE on January 29, 2014, concluded that older men, and younger men with pre-existing diagnosed heart disease, have an increased risk of heart attack following initiation of testosterone therapy.

About Schlichter, Bogard & Denton, LLP
Schlichter, Bogard & Denton, LLP is a unique law firm that has held numerous leadership positions in national litigations involving dangerous pharmaceutical medications, unsafe medical devices and toxic torts, including but not limited to: In re: Testosterone Replacement Therapy Products Liability Litigation (MDL 2545, Case No. 14-md-2545, N.D. Ill.), In re: Pradaxa® (Dabigatran Etexilate) Products Liability (MDL 2385, Case No. 12-md-2385, S.D. Ill.), In re: E.I. Du Pont de Nemours and Company C-8 Personal Injury Litigation (MDL 2433, Case No. 13-md-2433, S.D. Ohio), In re: Yasmin® and Yaz® (Drospirenone) Marketing and Sales Practices and Products Liability Litigation (MDL 2100, Case No. 09-md-2100, S.D. Ill.), In re: NuvaRing® Products Liability Litigation (MDL 1964, Case No. 08-md-1964, E.D. Mo.), In re: Gadolinium-Based Contrast Products Liability Litigation (MDL 1909, Case No. 08-md-50000, N.D. Ohio), and In re: Ortho Evra® Products Liability Litigation (MDL 1742, Case No. 06-md-40000, N.D. Ohio).

The Pharmaceuticals and Medical Litigation Department at Schlichter, Bogard & Denton aggressively represent clients who allege to have suffered injuries as a result of dangerous pharmaceutical medications and unsafe medical devices. The attorneys at Schlichter, Bogard & Denton, LLP who represent such victims include Roger Denton, Kristine Kraft, Beth Wilkins Flieger, Ashley Brittain Landers, and Tara Rocque. With hard work, creative thinking, and strong trial skills, we have earned an outstanding nationwide reputation by representing thousands of individuals who have suffered serious and life-threatening injuries, or even death.

If you or a loved one have suffered serious injuries after using testosterone therapy drugs, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.

Schlichter, Bogard & Denton, LLP also welcomes the opportunity to work with other attorneys on these types of cases. We are available to either handle these cases or work as co-counsel, so other attorneys with these types of cases are invited to contact an attorney at the firm to explore this opportunity.

The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.


Contact